Results 21 to 30 of about 316,189 (194)
Background. Although numerous reports addressing pathological involvements of diabetic polyneuropathy have been conducted, a universally effective treatment of diabetic polyneuropathy has not yet been established.
Tatsuhito Himeno +15 more
doaj +1 more source
Treatment of Diabetic Sensory Polyneuropathy [PDF]
No current disease-modifying treatments have been shown definitively in randomized clinical trials to reduce or reverse diabetic sensory polyneuropathy (DSP). It is increasingly recognized that individuals with "prediabetes" or impaired glucose regulation can already have a "small-fiber" neuropathy, or mild DSP, in which sensory axons of both small and
Lindsay, Zilliox, James W, Russell
openaire +2 more sources
Objective To achieve an accurate quantification in diabetic polyneuropathy (DPN), we developed a new electrophysiological index that we called the DPN index. The relationship between the DPN index and the neurological findings in diabetic patients was assessed.
Hemmi, Shoji +8 more
openaire +3 more sources
Alpha-Lipoic Acid for the Prevention of Diabetic Macular Edema [PDF]
Introduction: To evaluate the effect of alpha-lipoic acid (ALA) on the occurrence of diabetic macular edema. Methods: Randomized, double-blind, placebo-controlled, multicenter, multinational study. Patients were randomized to the treatment group with 600
Haritoglou, Christos +10 more
core +1 more source
Relation between Serum Uric Acid and Peripheral Neuropathy in Cases of Type 2 Diabetes Mellitus [PDF]
Background: Peripheral neuropathy is a common sequel of diabetes mellitus type 2, and may occur as an initial manifestation of diabetes. The role of uric acid in diabetic neuropathy as a microvascular complication of diabetes type 2 has been reported in ...
Hossam Ali, Ahmed Al-Adl
doaj +1 more source
Introduction: Diabetes mellitus with the prevalence rate of 8.9-12.3% in human population,ultimately leads to the peripheral nervous system involvement in many patients. It causes various types ofpolyneuropathies which may manifest abnormalities such as impaired nerve conduction velocity (NCV) and prolongedF-wave latency.
NASER ZANGIABADI, MD +2 more
openaire +2 more sources
A brain-based pain facilitation mechanism contributes to painful diabetic polyneuropathy [PDF]
The descending pain modulatory system represents one of the oldest and most fundamentally important neurophysiological mechanisms relevant to pain. Extensive work in animals and humans has shown how a functional imbalance between the facilitatory and ...
Segerdahl, Andrew +15 more
core +1 more source
Background Although previous reports have revealed the therapeutic potential of stem cell transplantation in diabetic polyneuropathy, the effects of cell transplantation on long-term diabetic polyneuropathy have not been investigated.
Maiko Omi +13 more
doaj +1 more source
Background Diabetic peripheral neuropathy (DPN) is one of the most common chronic microvascular complications in type 2 diabetes mellitus (T2DM). Hence, the present study aimed to investigate the association between Serum Uric Acid (SUA) levels and ...
Haniye Sadat Fayazi +4 more
doaj +1 more source
Neurobiological Opportunities in Diabetic Polyneuropathy
This review highlights a selection of potential translational directions for the treatment of diabetic polyneuropathy (DPN) currently irreversible and without approved interventions beyond pain management. The list does not include all diabetic targets that have been generated over several decades of research but focuses on newer work.
Trevor M. Poitras +2 more
openaire +2 more sources

